Program

Registration: Main Lobby

Icebreaker Activity/Networking Reception: Dolce Vita Patio

Meet your fellow CEOs

Welcome & Opening Remarks: Dolce Vita Garden 

Sara Jane Demy, Founder & CEO, Demy-Colton

CEO Summit Participant Introductions: Dolce Vita Garden

Fireside Chat Series: Dolce Vita Garden

The Purposeful CEO – Fulfilling the Promise 

Biotech CEOs, as well as CEOs that support the health ecosystem, are committed to improving the health of patients. The path they take to fulfill their objective of delivering better health outcomes is challenging and requires risk-taking on many levels.

• Moderator: Pankaj Oza, Managing Partner, Blue Matter
• Fireside Chat CEO: Dr. Claudia Ulbrich, CEO, Cardior Pharmaceuticals

Private Networking Breakfast: Entre Venias Patio

Summit Overview & Rules of Engagement: Ra Conference Room
Sara Jane Demy, Founder & CEO, Demy-Colton 

The Bioeconomy: Where Are We Today and Where Will We Be as We Head into 2025

With a change in the tides after a previously fractured economy, will the biotech sector in Europe keep its rightful place as a leader in innovation? Let’s discuss the predictions from our experts and consider how this will affect your company’s journey.

09:30

Fundraising:  Patience, Persistence, and Performance Pays in All Market Conditions

A discussion about building relationships with the investing community and potential partners that will lead to an investment or partnership to support your company. As well as what your company needs to consistently demonstrate to build confidence in your company.

Networking Break: Ra Conference Garden

10:30

The Path(s) Forward: Understanding the Strategic Options

Are you planning to go it alone, be acquired, or partner select assets? Let’s discuss various options to help advance your company.

For Successful BD and Fundraising: Every Company Has to Understand How Any Asset Will be Commercialized, Even at an Early Stage

It is critical for any company to demonstrate that they have a thorough understanding of how they will commercialize their assets, even at an early stage. Let’s explore strategies for successful product commercialization.

The Evolving Regulatory Environment:  Changes Underway in Europe and the US and How it Will Affect Market Access

The proposed European Parliament legislative overhaul designed to make Europe more attractive for the biopharma industry may not be so attractive, and, on the US side, is the IRA a Pandora’s box.

​​Networking Lunch: Seaview Terraza

Market Access: Which Markets Are Right for Your Product and Company?

Often, EU companies that are planning for commercialization will target the US market because of its size and the fact that it is a single market while not targeting local markets or other regional markets. Let’s discuss the options and the resources and tactics for both.

Valuation Case Study Breakout: Art Rooms

Valuation Report Back: Ra Conference Room

Boards: The Psychological Challenge of the Board Meeting

Why do CEOs often dread these meetings? What are the dynamics? Fears?  We will discuss where you can find support as a CEO and overcome these hurdles.

Day 1 Wrap-Up & Instructions for Games

Sara Jane Demy, Founder & CEO, Demy-Colton

Sara Pinto, Managing Director, Program Development, Demy-Colton

Biotech CEO Summit Europe Games: Entre Venias Patio

Biotech CEO Summit Europe Gala Dinner: Pool Deck

Private Networking Breakfast: Entre Venias Patio

Welcome Back & Day 2 Commences: Ra Conference Room

Sara Jane Demy, Founder & CEO, Demy-Colton 

Communications: A Tool to Help Achieve Your Corporate Goals

Reputation building is particularly challenging for biotech companies due to their business model. This intangible asset creates real value and therefore should be an objective for every company. A top-line interactive discussion and experience exchange on the critical role of strategic communications in building and maintaining the reputation and brand of your company. With a focus on external and internal alignment.

Business and Boards: Building a Trusted Relationship and Engagement to Support Success

Leading a company can be a turbulent ride in the biotech industry. Let’s consider how a CEO can get the board he/she needs.

Networking Break: Ra Conference Garden

Building a Smart Team & Keeping Them: The Essentials for Success

The team surrounding a CEO is critical to the success of the company. How do you assess the strengths of your team to understand its weaknesses to identify your needs?

Being a CEO Who Leads Through Difficult Times

A conversation with CEOs who have made it to the other side of countless challenges. What does it take personally and professionally to persevere and prosper in changing times.

An Unguarded Conversation Among Friends  

Is being a biotech CEO really the loneliest job in the world?  

Wrap Up Biotech CEO Summit   

Sara Jane Demy, Founder & CEO, Demy-Colton

Networking Luncheon and Closing: Dolce Vita Garden